Eligibility criteria were HIV infection, a concomitant advanced cancer, a CD4+ T-cell count greater than or equal to 100 cells/μL, cART for 4 or more weeks, and an HIV viral load of less than 200 copies/mL. Here, CD4 is linked to HIV infectious disease.